AXA Investment Managers »

Denali Therapeutics shares owned by AXA Investment Managers

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by AXA Investment Managers from 13F filings

Historical chart of AXA Investment Managers investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by AXA Investment Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by AXA Investment Managers

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3M 295k 14.52

More positions owned by AXA Investment Managers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Servicenow (NOW)
Ubs Group SHS (UBS)
Costco Wholesale Corporation (COST)
TJX Companies (TJX)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)

View all positions for AXA Investment Managers

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics